Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 4, 2024
Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host
Drew J Winston, Patricia A Young, Haran T Schlamm, et al.
Blood
|
August 20, 2004
Elimination of Aspergillus infection in allogeneic stem cell transplant recipients with long-term itraconazole prophylaxis: prevention is better than treatment
Drew J Winston, Christos Emmanouilides, Kathy Bartoni, et al.
Idcases
|
November 8, 2021
Utilization of whole genome sequencing for resolution of discrepant <i>Mycobacterium tuberculosis</i> drug susceptibility results: A case report
Susan Realegeno, Oladunni Adeyiga, Drew J Winston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2003
Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation
Drew J Winston, Andrew M Yeager, Pranatharthi H Chandrasekar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 2, 2006
Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract
Drew J Winston, Lindsey R Baden, Don A Gabriel, et al.
The Journal of Infectious Diseases
|
March 23, 2021
Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy
Nina Singh, Drew J Winston, Raymund R Razonable, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 27, 2020
Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors
Nina Singh, Drew J Winston, Raymund R Razonable, et al.
The Journal of Infectious Diseases
|
July 30, 2020
Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy
Nina Singh, Drew J Winston, Raymund R Razonable, et al.
Annals of Internal Medicine
|
May 6, 2003
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial
Drew J Winston, Richard T Maziarz, Pranatharthi H Chandrasekar, et al.
Transplantation
|
June 8, 2015
Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients
Nina Singh, Drew J Winston, Ajit P Limaye, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 4, 2024
Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host
Drew J Winston, Patricia A Young, Haran T Schlamm, et al.
Blood
|
August 20, 2004
Elimination of Aspergillus infection in allogeneic stem cell transplant recipients with long-term itraconazole prophylaxis: prevention is better than treatment
Drew J Winston, Christos Emmanouilides, Kathy Bartoni, et al.
Idcases
|
November 8, 2021
Utilization of whole genome sequencing for resolution of discrepant <i>Mycobacterium tuberculosis</i> drug susceptibility results: A case report
Susan Realegeno, Oladunni Adeyiga, Drew J Winston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 11, 2003
Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation
Drew J Winston, Andrew M Yeager, Pranatharthi H Chandrasekar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 2, 2006
Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract
Drew J Winston, Lindsey R Baden, Don A Gabriel, et al.
The Journal of Infectious Diseases
|
March 23, 2021
Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy
Nina Singh, Drew J Winston, Raymund R Razonable, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 27, 2020
Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors
Nina Singh, Drew J Winston, Raymund R Razonable, et al.
The Journal of Infectious Diseases
|
July 30, 2020
Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy
Nina Singh, Drew J Winston, Raymund R Razonable, et al.
Annals of Internal Medicine
|
May 6, 2003
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial
Drew J Winston, Richard T Maziarz, Pranatharthi H Chandrasekar, et al.
Transplantation
|
June 8, 2015
Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients
Nina Singh, Drew J Winston, Ajit P Limaye, et al.
Page
of 5